Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7577637

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of group
Business results of group
Cash and cash equivalents
381,816,000,000 JPY
315,986,000,000 JPY
350,213,000,000 JPY
Revenue
1,164,365,000,000 JPY
402,180,000,000 JPY
1,296,163,000,000 JPY
992,293,000,000 JPY
340,627,000,000 JPY
Profit (loss) before tax
180,238,000,000 JPY
156,886,000,000 JPY
167,402,000,000 JPY
Profit (loss), attributable to owners of parent
144,839,000,000 JPY
48,405,000,000 JPY
124,086,000,000 JPY
132,495,000,000 JPY
60,885,000,000 JPY
Comprehensive income, attributable to owners of parent
218,550,000,000 JPY
208,117,000,000 JPY
164,538,000,000 JPY
Equity attributable to owners of parent
1,570,424,000,000 JPY
1,460,308,000,000 JPY
1,466,291,000,000 JPY
Total assets
2,513,948,000,000 JPY
2,332,395,000,000 JPY
2,356,245,000,000 JPY
Basic earnings (loss) per share
79.43
26.56
67.08
71.51
32.86
Diluted earnings (loss) per share
79.40
67.05
71.47
Ratio of owners' equity to gross assets
0.625 xbrli:pure
0.626 xbrli:pure
0.622 xbrli:pure
Cash flows from (used in) operating activities
212,174,000,000 JPY
257,444,000,000 JPY
208,859,000,000 JPY
Cash flows from (used in) investing activities
-61,781,000,000 JPY
-62,413,000,000 JPY
-47,586,000,000 JPY
Cash flows from (used in) financing activities
-91,120,000,000 JPY
-216,298,000,000 JPY
-141,264,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.